Related references
Note: Only part of the references are listed.Hepatocellular carcinoma epidemiology
Cristina Bosetti et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2014)
Anti-diabetic medications and risk of primary liver cancer in persons with type II diabetes
K. W. Hagberg et al.
BRITISH JOURNAL OF CANCER (2014)
Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
Siddharth Singh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort
S. Schlesinger et al.
ANNALS OF ONCOLOGY (2013)
Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
Hsiao-Ping Chen et al.
GUT (2013)
Increased Risk of Gastrointestinal Malignancy in Patients with Diabetes Mellitus and Correlations with Anti-Diabetes Drugs: A Nationwide Population-based Study in Taiwan
Chun-Chih Chiu et al.
INTERNAL MEDICINE (2013)
Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
Russell A. Miller et al.
NATURE (2013)
Effects of Sulfonylureas on Tumor Growth: A Review of the Literature
Giulia Pasello et al.
ONCOLOGIST (2013)
Cancer Risk for Patients Using Thiazolidinediones for Type 2 Diabetes: A Meta-Analysis
Cristina Bosetti et al.
ONCOLOGIST (2013)
Risk of Hepatocellular Carcinoma in Diabetic Patients and Risk Reduction Associated With Anti-Diabetic Therapy: A Population-Based Cohort Study
Shih-Wei Lai et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Diabetes and cancer II: role of diabetes medications and influence of shared risk factors
Adedayo A. Onitilo et al.
CANCER CAUSES & CONTROL (2012)
Lower Risk of Cancer in Patients on Metformin in Comparison With Those on Sulfonylurea Derivatives Results from a large population-based follow-up study
Rikje Ruiter et al.
DIABETES CARE (2012)
Metformin and the Risk of Cancer Time-related biases in observational studies
Samy Suissa et al.
DIABETES CARE (2012)
Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus
Chia-Hsuin Chang et al.
HEPATOLOGY (2012)
Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: A systematic review and meta-analysis of cohort studies
Chenggang Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Oral Insulin Secretagogues, Insulin, and Cancer Risk in Type 2 Diabetes Mellitus
Chia-Hsuin Chang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Diabetes Mellitus and Cancer Risk in a Network of Case-Control Studies
Cristina Bosetti et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2012)
Diabetes, cancer, and metformin: connections of metabolism and cell proliferation
Emily Jane Gallagher et al.
YEAR IN DIABETES AND OBESITY (2011)
Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals
Meei-Shyuan Lee et al.
BMC CANCER (2011)
Understanding the benefit of metformin use in cancer treatment
Ryan J. O. Dowling et al.
BMC MEDICINE (2011)
Diabetes mellitus, medications for type 2 diabetes mellitus, and cancer risk
Carlo La Vecchia
METABOLISM-CLINICAL AND EXPERIMENTAL (2011)
Cancer incidence in type 2 diabetes patients - first results from a feasibility study of the D2C cohort
Hans-Werner Hense et al.
DIABETOLOGY & METABOLIC SYNDROME (2011)
Association of Diabetes Duration and Diabetes Treatment With the Risk of Hepatocellular Carcinoma
Manal M. Hassan et al.
CANCER (2010)
Metformin and reduced risk of hepatocellular carcinoma in diabetic patients with chronic liver disease
Valter Donadon et al.
LIVER INTERNATIONAL (2010)
Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes
D. M. Nathan et al.
DIABETOLOGIA (2009)
Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease
Valter Donadon et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Cancer incidence among patients treated with antidiabetic pharmacotherapy
Susan A. Oliveria et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2008)
Menopause hormone replacement therapy and cancer risk: an Italian record linkage investigation
G. Corrao et al.
ANNALS OF ONCOLOGY (2008)
AMP-activated protein kinase in metabolic control and insulin signaling
Mhairi C. Towler et al.
CIRCULATION RESEARCH (2007)
Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease
Keith G. Tolman et al.
DIABETES CARE (2007)
AMP-activated protein kinase - the fat controller of the energy railroad
Gregory R. Steinberg et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2006)
The association between diabetes and hepatocellular carcinoma: A systematic review of epidemiologic evidence
HB El-Serag et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin
SL Bowker et al.
DIABETES CARE (2006)
Predictors of glycemic control among patients with Type 2 diabetes: A longitudinal study
SR Benoit et al.
BMC PUBLIC HEALTH (2005)
Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma
HB El-Serag et al.
GASTROENTEROLOGY (2004)
Evaluating medication effects outside of clinical trials: New-user designs
WA Ray
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
